Shu Kam Mok
Director/Board Member at ASTRAZENECA PLC
Net worth: 269 780 $ as of 2024-03-30
Profile
Shu Kam Mok is the founder of Sanomics Ltd.
(founded in 2015) and holds the title of Chairman.
Dr. Mok is also the founder of Chinese Thoracic Oncology Group, Asia Thoracic Oncology Research Group, and Aurora Tele-Oncology Ltd.
Dr. Mok's current job(s) include being an Independent Non-Executive Director at AstraZeneca PLC since 2019, an Independent Non-Executive Director at HUTCHMED (China) Ltd.
since 2017, and a Director at the American Society of Clinical Oncology, Inc., a Non-Executive Independent Director at Lunit Usa, Inc., and the Secretary of the Chinese Society of Clinical Oncology.
Dr. Mok's former job(s) include being the Chairman of the Clinical Oncology Department at The Chinese University of Hong Kong, the Chairman of Act Genomics Co. Ltd., and the Treasurer of the International Association for the Study of Lung Cancer.
Dr. Mok's education history includes undergraduate and doctorate degrees from the University of Alberta.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ASTRAZENECA PLC
0.00% | 2023-12-30 | 2,000 ( 0.00% ) | 269 780 $ | 2024-03-30 |
HUTCHMED (CHINA) LIMITED
-.--% | 2023-10-19 | 0 ( -.--% ) | - $ | 2024-03-30 |
Shu Kam Mok active positions
Companies | Position | Start |
---|---|---|
ASTRAZENECA PLC | Director/Board Member | 2018-12-31 |
HUTCHMED (CHINA) LIMITED | Director/Board Member | 2016-12-31 |
Sanomics Ltd.
Sanomics Ltd. Miscellaneous Commercial ServicesCommercial Services Sanomics Ltd. is a biotechnology company located in Science Park. The Chinese company aims to transform cancer treatments by offering secure and effective liquid-based and tissue-based genomic tests to patients. Sanomics was founded in 2015 by Tony Mok, and the CEO is Stanley Sy Ming-Yiu. | Founder | 2014-12-31 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Director/Board Member | - |
Chinese Society of Clinical Oncology | Corporate Secretary | - |
Lunit Usa, Inc. | Director/Board Member | - |
Former positions of Shu Kam Mok
Companies | Position | End |
---|---|---|
Act Genomics Co. Ltd.
Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Chairman | 2021-12-31 |
Aurora Tele-Oncology Ltd.
Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Aurora Tele-Oncology Ltd. operates an oncology-specific teleconsultation platform striving to improve cancer care. The private company is based in Hong Kong, Hong Kong. The Chinese company was founded by Shu Kam Mok. | Founder | - |
Chinese Thoracic Oncology Group | Founder | - |
░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░ | - |
░░░ ░░░░░░░ ░░░░░░░░░░ ░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Shu Kam Mok
University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
HUTCHMED (CHINA) LIMITED | Health Technology |
Private companies | 9 |
---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
International Association for the Study of Lung Cancer | |
Act Genomics Co. Ltd.
Act Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services ACT Genomics Co. Ltd. develops cancer molecular information and therapeutic solutions. It specializes in oncology, cancer genomics, and bioinformatics. The company was founded by Shu Jen Chen and Hua Chien Chen in 2014 and is headquartered in Taipei, Taiwan. | Health Services |
Chinese Society of Clinical Oncology | |
Sanomics Ltd.
Sanomics Ltd. Miscellaneous Commercial ServicesCommercial Services Sanomics Ltd. is a biotechnology company located in Science Park. The Chinese company aims to transform cancer treatments by offering secure and effective liquid-based and tissue-based genomic tests to patients. Sanomics was founded in 2015 by Tony Mok, and the CEO is Stanley Sy Ming-Yiu. | Commercial Services |
Chinese Thoracic Oncology Group | |
Asia Thoracic Oncology Research Group | |
Aurora Tele-Oncology Ltd.
Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Aurora Tele-Oncology Ltd. operates an oncology-specific teleconsultation platform striving to improve cancer care. The private company is based in Hong Kong, Hong Kong. The Chinese company was founded by Shu Kam Mok. | Health Services |
Lunit Usa, Inc. |
- Stock Market
- Insiders
- Shu Kam Mok